The challenges posed by reemerging Clostridium difficile infection. - Test2 - elhamkhani - TriplyDB

The challenges posed by reemerging Clostridium difficile infection.

The challenges posed by reemerging Clostridium difficile infection.

http://www.wikidata.org/entity/Q30229530

about

Infections and Chronic Inflammatory Bowel Disease Clostridium difficile infection: molecular pathogenesis and novel therapeutics Escherichia coli and selected veterinary and zoonotic pathogens isolated from environmental sites in companion animal veterinary hospitals in southern Ontario.Metabolism of bile salts in mice influences spore germination in Clostridium difficile Glutamine and alanyl-glutamine increase RhoA expression and reduce Clostridium difficile toxin-a-induced intestinal epithelial cell damage Adenosine deaminase inhibition prevents Clostridium difficile toxin A-induced enteritis in mice.Piglet models of acute or chronic Clostridium difficile illness.Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model.Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.Factors associated with Clostridium difficile diarrhea in a hospital in Beijing, China The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.The identification and epidemiology of meticillin-resistant Staphylococcus aureus and Clostridium difficile in patient rooms and the ward environment.Equine colitis X associated with infection by Clostridium difficile NAP1/027.Bowel preparation for colectomy and risk of Clostridium difficile infection.Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models Clostridium difficile infection in outpatients, Maryland and Connecticut, USA, 2002-2007.Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results Clostridium difficile ribotype does not predict severe infection.Clostridium difficile: the increasingly difficult pathogen.Clostridium difficile infection: a re-emerging threat.Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.Clostridium difficile associated infection, diarrhea and colitis Microarray identification of Clostridium difficile core components and divergent regions associated with host origin.Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm?A novel biologic immunomodulator, HDFx, protects against lethal hemorrhage, endotoxins and traumatic injury: potential relevance to emerging diseases.A novel subtyping assay for detection of Clostridium difficile virulence genes.Carvacrol and trans-cinnamaldehyde reduce Clostridium difficile toxin production and cytotoxicity in vitro.The enterotoxicity of Clostridium difficile toxins.Nosocomial diarrhea: a review of pathophysiology, etiology, and treatment strategies.Clostridial binary toxins: iota and C2 family portraits.Clostridium colitis: challenges in diagnosis and treatment.Homogeneous and digital proximity ligation assays for the detection of Clostridium difficile toxins A and B.Clostridium difficile-associated diarrhea after antibiotic treatment for traveler's diarrhea.Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection.Essential role of the glucosyltransferase activity in Clostridium difficile toxin-induced secretion of TNF-alpha by macrophages.Clostridium difficile Infection: An Emerging Cause of Death in the Twenty-First Century.Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B.Evaluation of a chromogenic culture medium for the detection of Clostridium difficile.

P2860

Q26796518-D839C7D2-B593-4A29-8252-501C965C8CA4 Q26864237-CFE435B7-2B9F-4F0C-B449-1848F4E16580 Q27692069-E5099403-37E5-4F0F-A345-12BEB7995E2E Q28472543-C2C4D2E8-CDB5-476C-8BED-6EFAB62A8694 Q30421944-FCDFB193-5BE4-468A-A4D6-2A8C09734B2F Q30431245-1299F69B-F60B-4CC9-8285-3AC7A8E7317F Q33583467-796A7BA0-EA26-497D-A25A-23E3512EAACD Q33586133-23A84CEC-1952-43DB-AFCA-6E597596BA4D Q34058125-8B473A64-3C9B-4BB5-9498-2088812384A5 Q34574295-62B3765C-99EF-400E-935C-2EBBAB19BA14 Q34623572-FF055A80-5C66-4AB0-AF9C-9CA0754D8254 Q34624447-1E29E258-C0AC-4F57-92F2-5854269696D3 Q34862890-686F0C54-AF14-4326-BB50-E03B4BD8FA99 Q34978636-E4CB3DE7-E0A0-4A99-97A9-575EA5972390 Q35037050-B70ABB19-5C32-4242-9E49-9A5EE3009EBB Q35669017-D6D89BFB-9423-43B8-ACE1-5AFBAE7AE1DA Q35847588-D624F468-F858-49D0-BCE6-02876F36358B Q35867764-E6F851D2-F7FF-40DA-8938-F165A6B7D4F5 Q36408941-38A6DF79-CA48-494A-B301-902777DB6216 Q36642088-6310F5D4-A65A-4389-96C1-A839B57BA8AD Q36827540-CADFCF0E-262C-4107-BE5B-0DC2252C33EE Q36909955-AD6484AF-4405-40CA-9631-422CC64EF66B Q37160538-AC1805C8-91B5-4D06-BC01-527014F0992E Q37232515-DE56F937-0784-442F-9639-CA1489F9076C Q37287190-25E3DDE6-0C35-45BB-BC67-85350751434B Q37412605-B47FD9D9-3228-41DE-828A-83A0A74D181A Q37608243-CDB2E6A8-360C-467E-8AD1-48661606026E Q37684070-6C458206-2C9B-4686-8EEE-C44362A34C5A Q37954308-71F390FE-CA6D-43B2-B01F-89DDFE67EC95 Q37992488-CBEE4267-D5A1-496A-A11F-253563DDDC1C Q38037529-BAC9B251-A635-433A-9131-90ED1EE10703 Q38247224-AA8D1150-8DD2-49D1-A614-10769F71A3B9 Q38289720-F8DA3F75-AC92-4DDB-BE67-C9AD25CF439C Q39309213-993EA6C3-D058-4057-85DD-06C6222D50C4 Q39600494-F93AE3BD-BFBB-4D27-AF0D-815E3DB5EF3E Q39760796-FAE33BED-DD2A-41A8-AE9F-9F179542615C Q39867842-9CE19C0A-30AE-44A0-BF4A-A15DEAC36571 Q40639036-112DBEF7-7586-4FBC-8978-4125EE2F2F64 Q41222915-A16A4675-3DF0-4D8E-BE6A-310F94E7D88B Q41484717-320D7B5F-428E-47CC-A891-DFD3BADD9A28

P2860

The challenges posed by reemerging Clostridium difficile infection.

http://www.wikidata.org/entity/Q30229530

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The challenges posed by reemerging Clostridium difficile infection.

@ast

The challenges posed by reemerging Clostridium difficile infection.

@en

type

label

The challenges posed by reemerging Clostridium difficile infection.

@ast

The challenges posed by reemerging Clostridium difficile infection.

@en

prefLabel

The challenges posed by reemerging Clostridium difficile infection.

@ast

The challenges posed by reemerging Clostridium difficile infection.

@en

P1433

Q30229530-97977968-7C67-4CBD-BBC7-9E32D2C05378

P1476

Q30229530-C4DAA749-EE24-445A-A92E-3351892F0BB4

P2093

Q30229530-1EC5FDF8-84CA-4038-B0A4-42D03885182F

Q30229530-9D174224-DD25-4105-B1F2-8C8B37CCF545

P2860

Q30229530-04FE7C15-7209-4FA6-B561-0B8CB9671782

Q30229530-0B87CAF5-9B99-42F9-91B9-2ADA41437029

Q30229530-1031B2BB-F33D-427F-91BE-1AC8583FAF76

Q30229530-11BA7B1B-4D72-4DC0-AACC-1F6C18399DD0

Q30229530-11E709E2-2D74-4060-BC11-D771C330CA90

Q30229530-1284650A-E08D-4741-A0BA-17C57AE0666C

Q30229530-12F1DFCA-F009-4D26-AA40-80FBFA1A7E4F

Q30229530-19B4091D-0668-48AB-AAE4-5600A1B6164E

Q30229530-20AD198D-AB56-4ECF-B7EC-620468D88B88

Q30229530-273A761D-6D76-442B-9E74-FF7482E5F4E3

P304

Q30229530-7A485DA6-F3C3-4278-97EF-766B6C9A3B1E

P31

Q30229530-08B27750-0520-439D-8D95-CDB71A7D5DBC

P356

Q30229530-C04D0DE1-2EAB-40E5-9ECA-4A4DE4AC3454

P407

Q30229530-AA17CF8F-95E8-41F4-A70E-074EAC8B46A6

P433

Q30229530-0B031BB6-A273-4794-8A14-0DD2B5788C48

P478

Q30229530-9D922F96-717B-48B6-BEE5-BDAF933EC4B0

P577

Q30229530-C87C3B8C-3908-4823-9411-D4D32AC2485B

P5875

Q30229530-0AAD4ED7-541C-48EB-AAE8-7CF526F36A65

P698

Q30229530-8528F551-1B4E-46A9-8BFE-A72E67552F2A

P921

Q30229530-5E475507-CD93-4BBD-83B8-AD619392F570

P356

P1433

Clinical Infectious Diseases

P1476

The challenges posed by reemerging Clostridium difficile infection.

@en

P2093

David B Blossom

http://www.w3.org/2001/XMLSchema#string

L Clifford McDonald

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.

Nitazoxanide for the treatment of Clostridium difficile colitis.

Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

An epidemic, toxin gene-variant strain of Clostridium difficile.

P304

222-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/518874

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6258016

http://www.w3.org/2001/XMLSchema#string

P698

17578783

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile